An official website of the United States government
2013 BRFSS Asthma Call-Back Survey Prevalence Tables
TABLE 9. Estimated percent using an inhaled corticosteroid in the past 3 months among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2013
| State/Territory | Current | Active | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| Alabama | 129 | 36.7 | 7.8 | (21.4 – 52.0) | 138 | 31.7 | 7.2 | (17.6 – 45.8) |
| Arizona | 103 | 38.3 | 10.5 | (17.7 – 58.9) | 105 | 39.4 | 10.5 | (18.8 – 60.0) |
| California | 168 | 28.5 | 4.9 | (18.9 – 38.1) | 184 | 31.4 | 4.7 | (22.2 – 40.6) |
| Connecticut | 212 | 48.8 | 6.7 | (35.7 – 61.9) | 232 | 46.7 | 6.4 | (34.2 – 59.2) |
| Florida | 724 | 33.4 | 4.9 | (23.8 – 43.0) | 767 | 34.4 | 4.8 | (25.0 – 43.8) |
| Georgia | 122 | 32.4 | 7.1 | (18.5 – 46.3) | 132 | 31.5 | 6.8 | (18.2 – 44.8) |
| Hawaii | 110 | 42.1 | 10.3 | (21.9 – 62.3) | 110 | 40.2 | 10.4 | (19.8 – 60.6) |
| Indiana | 319 | 44.5 | 5.4 | (33.9 – 55.1) | 334 | 43.4 | 5.2 | (33.2 – 53.6) |
| Iowa | 208 | 39.0 | 7.6 | (24.1 – 53.9) | 212 | 38.6 | 7.2 | (24.5 – 52.7) |
| Kansas | 627 | 32.1 | 3.3 | (25.6 – 38.6) | 655 | 32.6 | 3.3 | (26.1 – 39.1) |
| Kentucky | 334 | 31.1 | 4.6 | (22.1 – 40.1) | 363 | 28.1 | 4.2 | (19.9 – 36.3) |
| Louisiana | 125 | 28.4 | 6.3 | (16.1 – 40.7) | 144 | 19.2 | 5.1 | (9.2 – 29.2) |
| Maine | 223 | 30.4 | 4.6 | (21.4 – 39.4) | 240 | 29.2 | 4.4 | (20.6 – 37.8) |
| Maryland | 225 | 34.0 | 5.5 | (23.2 – 44.8) | 243 | 32.8 | 5.3 | (22.4 – 43.2) |
| Massachusetts | 142 | 34.5 | 8.2 | (18.4 – 50.6) | 151 | 32.0 | 7.3 | (17.7 – 46.3) |
| Michigan | 461 | 41.1 | 4.1 | (33.1 – 49.1) | 494 | 38.9 | 3.9 | (31.3 – 46.5) |
| Mississippi | 214 | 28.6 | 5.6 | (17.6 – 39.6) | 217 | 29.3 | 5.8 | (17.9 – 40.7) |
| Missouri | 213 | 31.7 | 5.0 | (21.9 – 41.5) | 220 | 31.9 | 4.9 | (22.3 – 41.5) |
| Montana | 257 | 24.8 | 4.8 | (15.4 – 34.2) | 275 | 23.9 | 4.5 | (15.1 – 32.7) |
| Nebraska | 262 | 27.2 | 5.3 | (16.8 – 37.6) | 283 | 25.1 | 4.6 | (16.1 – 34.1) |
| Nevada | 100 | 28.7 | 7.5 | (14.0 – 43.4) | 115 | 27.5 | 7.1 | (13.6 – 41.4) |
| New Hampshire | 216 | 21.7 | 3.7 | (14.4 – 29.0) | 228 | 20.1 | 3.5 | (13.2 – 27.0) |
| New Jersey | 251 | 29.5 | 5.4 | (18.9 – 40.1) | 282 | 24.7 | 4.7 | (15.5 – 33.9) |
| New Mexico | 223 | 34.5 | 5.2 | (24.3 – 44.7) | 238 | 33.3 | 5.1 | (23.3 – 43.3) |
| New York | 112 | N/A | N/A | (N/A – N/A) | 112 | 24.1 | 7.2 | (10.0 – 38.2) |
| North Carolina | 106 | 43.4 | 8.7 | (26.3 – 60.5) | 124 | 41.3 | 8.0 | (25.6 – 57.0) |
| Ohio | 244 | 40.6 | 6.1 | (28.6 – 52.6) | 256 | 41.1 | 6.0 | (29.3 – 52.9) |
| Oklahoma | 222 | 25.9 | 4.0 | (18.1 – 33.7) | 231 | 26.5 | 3.9 | (18.9 – 34.1) |
| Oregon | 161 | 39.3 | 7.7 | (24.2 – 54.4) | 178 | 37.6 | 7.4 | (23.1 – 52.1) |
| Pennsylvania | 247 | 42.6 | 5.9 | (31.0 – 54.2) | 265 | 38.1 | 5.4 | (27.5 – 48.7) |
| Rhode Island | 196 | 33.1 | 5.4 | (22.5 – 43.7) | 208 | 32.9 | 5.3 | (22.5 – 43.3) |
| Texas | 208 | 31.7 | 7.4 | (17.2 – 46.2) | 231 | 30.9 | 7.1 | (17.0 – 44.8) |
| Utah | 303 | 32.7 | 6.1 | (20.7 – 44.7) | 320 | 32.2 | 5.8 | (20.8 – 43.6) |
| Vermont | 189 | 33.6 | 5.7 | (22.4 – 44.8) | 201 | 34.1 | 5.6 | (23.1 – 45.1) |
| Washington | 286 | 26.3 | 3.9 | (18.7 – 33.9) | 294 | 28.1 | 4.1 | (20.1 – 36.1) |
| West Virginia | 125 | 29.2 | 4.7 | (20.0 – 38.4) | 125 | 29.4 | 4.7 | (20.2 – 38.6) |
| Wisconsin | 188 | 39.5 | 6.7 | (26.4 – 52.6) | 190 | 35.8 | 7.3 | (21.5 – 50.1) |
| Puerto Rico | 205 | 35.5 | 5.8 | (24.1 – 46.9) | 246 | 31.9 | 5.2 | (21.7 – 42.1) |
| 38 state total | 8,760 | 33.1 | 1.4 | (30.4 – 35.8) | 9,343 | 32.8 | 1.3 | (30.3 – 35.3) |
| Median | 33.1 | 32.0 | ||||||
| Range | 21.7-48.8 | 19.2-46.7 | ||||||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30